NCT05692102

Brief Summary

Evaluate quality of life after gynaecological malignancies diagnosis and treatment

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 11, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 20, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

January 20, 2023

Status Verified

January 1, 2023

Enrollment Period

1.6 years

First QC Date

January 11, 2023

Last Update Submit

January 11, 2023

Conditions

Gynecologic Cancer

Outcome Measures

Primary Outcomes (1)

  • Evaluate quality of life after gynaecological malignancies diagnosis and treatment

    Evaluate quality of women life after gynaecological malignancies diagnosis and treatment

    2 years

Interventions

Evaluate quality of life after gynaecological malignancies diagnosis and treatmentOTHER

diagnosis and treatment

Eligibility Criteria

Age20 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Eligible women admitted to Assiut University Women health Hospital

You may not qualify if:

  • pre-existing psychological disorders 2.Stage 4 3.severe medical complications as cardiac pt 4.Morbid obesity BMI\<40

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Therapeutics

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

January 11, 2023

First Posted

January 20, 2023

Study Start

June 1, 2023

Primary Completion

January 1, 2025

Study Completion

June 1, 2025

Last Updated

January 20, 2023

Record last verified: 2023-01